Pediatric drug approval is crucial because children are not just small adults; they have unique physiological and developmental characteristics that can affect drug metabolism, efficacy, and safety. Without proper clinical trials and regulatory approval specifically for pediatric use, children may be at risk of adverse effects or suboptimal therapeutic outcomes.
